The researchers have demonstrated increased serum C-peptide, reflecting raised insulin secretion, is as a biomarker for obesity and insulin resistance, especially in T2DM and metabolic syndrome (MS) [3]. The gene discussed is INS; the disease is metabolic syndrome.